國家衛生研究院 |
2022-01 |
Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients
|
Blanchard, P;Lee, AWM;Carmel, A;Wai Tong, N;Ma, J;Chan, ATC;Hong, RL;Chen, MY;Chen, L;Li, WF;Huang, PY;Kwong, DLW;Poh, SSX;Ngan, R;Mai, HQ;Ollivier, C;Fountzilas, G;Zhang, L;Bourhis, J;Aupérin, A;Lacas, B;Pignon, JP;Benhamou, E;Chakrabandhu, S;Tc Chan, A;Chen, QY;Chen, Y;Chappell, RJ;Choi, H;Tt Chua, D;Lee Kiang Chua, M;Higgins, J;Hong, MH;Hong, RL;Pun Hui, E;Hsiao, CF;Kam, M;Angeliki Koliou, G;Lw Kwong, D;Lai, SC;On Lam, K;LeBlanc, ML;Wm Lee, A;Fun Victor Lee, H;Fei Li, W;Ma, B;Mo, F;Moon, J;Tong Ng, W;O'Sullivan, B;Petit, C;Pierre Pignon, J;Poh, SX;Rücker, G;Sham, J;Lim Soong, Y;Sun, Y;Tan, T;Tang, LQ;Tung, Y;Wee, J;Wu, X;Xu, T;Zhang, Y;Zhu, G;on behalf of the MACNPCcG |